Sindrome.del.Ovario.Poliquistico

Aspectos genéticos 41
drome. Clin Endocrinol (Oxf). 1996;44:
85-90.
106
Urbanek M, Du Y, Silander K, et al.
Variation in resistin gene promoter
not associated with polycystic ovary
syndrome. Diabetes. 2003;52:214-7.
107
Oksanen L, Tiitinen A, Kaprio J, Koistinen
HA, Karonen S, Kontula K. No evidence
for mutations of the leptin or
leptin receptor genes in women with
polycystic ovary syndrome. Mol Hum
Reprod. 2000;6:873-6.
108
Heinonen S, Korhonen S, Hippelainen
M, Hiltunen M, Mannermaa A, Saarikoski
S. Apolipoprotein E alleles in women
with polycystic ovary syndrome. Fertil
Steril. 2001;75:878-80.
109
Fernández-Real JM, Ricart W. Insulin
resistance and chronic cardiovascular
inflammatory syndrome. Endocr Rev.
2003;24:278-301.
110
Hotamisligil GS, Arner P, Caro JF,
Atkinson RL, Spiegelman BM. Increased
adipose tissue expression of tumor
necrosis factor-alpha in human obesity
and insulin resistance. J Clin Invest.
1995;95:2409-15.
111
Hotamisligil GS, Arner P, Atkinson RL,
Spiegelman BM. Differential regulation
of the p80 tumor necrosis factor
receptor in human obesity and insulin
resistance. Diabetes. 1997;46:451-5.
112
Bastard JP, Jardel C, Bruckert E, et al.
Elevated levels of interleukin 6 are
reduced in serum and subcutaneous
adipose tissue of obese women after
weight loss. J Clin Endocrinol Metab.
2000;85:3338-42.
113
González F, Thusu K, Abdel-Rahman
E, Prabhala A, Tomani M, Dandona P.
Elevated serum levels of tumor necrosis
factor alpha in normal-weight women
with polycystic ovary syndrome. Metabolism.
1999;48:437-41.
114
Escobar-Morreale HF, Calvo RM, Sancho
J, San Millán JL. TNF-alpha and hyperandrogenism:
a clinical, biochemical,
and molecular genetic study. J Clin
Endocrinol Metab. 2001;86:3761-7.
115
Sayin NC, Gucer F, Balkanli-Kaplan P,
et al. Elevated serum TNF-alpha levels
in normal-weight women with polycystic
ovaries or the polycystic ovary
syndrome. J Reprod Med. 2003;48:
165-70.
116
Escobar-Morreale HF, Villuendas G,
Botella-Carretero JI, Sancho J, San
Millán JL. Obesity, and not insulin
resistance, is the major determinant of
serum inflammatory cardiovascular risk
markers in pre-menopausal women.
Diabetologia. 2003;46:625-33.
117
Mohlig M, Spranger J, Osterhoff M,
et al. The polycystic ovary syndrome
per se is not associated with increased
chronic inflammation. Eur J Endocrinol.
2004;150:525-32.
118
Spaczynski RZ, Arici A, Duleba AJ.
Tumor necrosis factor-alpha stimulates
proliferation of rat ovarian theca-interstitial
cells. Biol Reprod. 1999;61:993-8.
119
Roby KF, Terranova PF. Effects of tumor
necrosis factor-alpha in vitro on steroidogenesis
of healthy and atretic follicles
of the rat: theca as a target. Endocrinology.
1990;126:2711-8.
120
Kaipia A, Chun SY, Eisenhauer K, Hsueh
AJ. Tumor necrosis factor-alpha and its
second messenger, ceramide, stimulate
apoptosis in cultured ovarian follicles.
Endocrinology. 1996;137:4864-70.
121
Geurts JM, Janssen RG, Van Greevenbroek
MM, et al. Identification of
TNFRSF1B as a novel modifier gene
in familial combined hyperlipidemia.
Hum Mol Genet. 2000;9:2067-74.
122
Glenn CL, Wang WY, Benjafield AV,
Morris BJ. Linkage and association of
tumor necrosis factor receptor 2 locus
with hypertension, hypercholesterolemia
and plasma shed receptor. Hum
Mol Genet. 2000;9:1943-9.
123
Peral B, San Millán JL, Castello R,
Moghetti P, Escobar-Morreale HF. The
methionine 196 arginine polymorphism
in exon 6 of the TNF receptor 2 gene
(TNFRSF1B) is associated with the
polycystic ovary syndrome and hyper-